Peer-reviewedCC BYDiagnostics (Basel, Switzerland)
BRAFV600E-Informed TI-RADS Reclassification of Biopsy Eligibility in Thyroid Nodules: A Retrospective Oracle Decision–Simulation Study
- 1Department of Ultrasound, China-Japan Friendship Hospital, Beijing 100029, China
- 2Key Laboratory of Big Data-Based Precision Medicine, School of Engineering Medicine, , Beijing 100191, China
- 3College of Information Science and Technology, , Beijing 100029, China
Related
- Real-World Eligibility for FLAURA, FLAURA2, and MARIPOSA in Patients with EGFR-Mutated Advanced NSCLC: A Retrospective Single-Center Study
- p38α orchestrates BRAFV600E-melanoma progression and immunotherapy response via tumor fitness and immune microenvironment modulation.
- Divergent aortic root cusp-to-cusp measurement techniques on CMR: geometric implications and threshold reclassification
- From Spiradenocarcinoma to Spiradenoma: A Case of Histopathological Diagnostic Reclassification
- Gallium-68 (68Ga)-Labelled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Initial Staging of High-Risk Prostatic Adenocarcinoma: Reclassification to Oligometastatic Disease and Change in Treatment Intent
BibTeX
@article{ma2026brafv600einformed,
title = {{BRAFV600E-Informed TI-RADS Reclassification of Biopsy Eligibility in Thyroid Nodules: A Retrospective Oracle Decision–Simulation Study}},
author = {Jiaojiao Ma and Xuehua Xi and Yang Li and Shanshan Wang and Ruyu Liu and Xuejiao Yu and Wanlin Huang and Mingyu Feng and Yong Cheng and Bo Zhang},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13664231},
note = {CC BY},
}
RIS
TY - JOUR
TI - BRAFV600E-Informed TI-RADS Reclassification of Biopsy Eligibility in Thyroid Nodules: A Retrospective Oracle Decision–Simulation Study
AU - Jiaojiao Ma
AU - Xuehua Xi
AU - Yang Li
AU - Shanshan Wang
AU - Ruyu Liu
AU - Xuejiao Yu
AU - Wanlin Huang
AU - Mingyu Feng
AU - Yong Cheng
AU - Bo Zhang
PY - 2026
DA - 2026/10/01
JO - Diagnostics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13664231
SN - 2075-4418
ER -